France Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012

Product Code GMD15183
Publication Date June 2008
Publisher Global Markets Direct
Product Type Report
Pages 305
ISBN Number not applicable
Change currency
PDF £1,895.00 €2,282 $2,996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

France Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012

This report is an essential source for in-depth information and data relating to the France Diabetes Care Devices devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the Diabetes Care Devices in France

Scope

  • The report provides diabetes care devices information broken down into detailed categories and segments in France.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the diabetes care devices market in France.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About
    • 2.2 Definitions
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Sector Review
    • 3.2 Healthcare Expenditure
    • 3.3 Healthcare Infrastructure
    • 3.4 Healthcare Policy
  • 4 Diabetes Care Devices in France
    • 4.1 Diabetes Care Devices Overall Revenues (2000-2012)
    • 4.2 Diabetes Care Devices Overall Volume (2000-2012)
    • 4.3 Diabetes Care Devices Overall Company Share (2006-2007)
  • 5 Glucose Monitoring in France
    • 5.1 Glucose Monitoring Overall Revenues (2000-2012)
    • 5.2 Glucose Monitoring Overall Volume (2000-2012)
    • 5.3 Glucose Monitoring Average Price (2000-2012)
    • 5.4 Glucose Monitoring Distribution Share (2006-2007)
    • 5.5 Glucose Monitoring Company Share (2006-2007)
  • 6 Insulin Delivery in France
    • 6.1 Insulin Delivery Overall Revenues (2000-2012)
    • 6.2 Insulin Delivery Overall Volume (2000-2012)
    • 6.3 Insulin Delivery Average Price (2000-2012)
    • 6.4 Insulin Delivery Distribution Share (2006-2007)
    • 6.5 Insulin Delivery Company Share (2006-2007)
  • 7 F. Hoffmann-La Roche Ltd. Company Profile
    • 7.1 Company Overview
    • 7.2 Business Overview
    • 7.3 Value Chain Analysis
    • 7.4 SWOT Analysis
    • 7.5 Financial and Operational Review
    • 7.6 Locations And Subsidiaries
    • 7.7 Financial Deals Landscape
    • 7.8 Recent Developments
  • 8 LifeScan, Inc. Company Profile
    • 8.1 Company Overview
    • 8.2 Business Overview
    • 8.3 Locations And Subsidiaries
    • 8.4 Recent Developments
    • 8.5 LifeScan, Inc. Pipeline Products
  • 9 Abbott Laboratories Company Profile
    • 9.1 Company Overview
    • 9.2 Business Overview
    • 9.3 Value Chain Analysis
    • 9.4 SWOT Analysis
    • 9.5 Financial and Operational Review
    • 9.6 Locations and Subsidiaries
    • 9.7 Financial Deals Landscape
    • 9.8 Recent Developments
    • 9.9 Abbott Laboratories Pipeline Products
  • 10 Novo Nordisk A/S Company Profile
    • 10.1 Company Overview
    • 10.2 Business Overview
    • 10.3 Locations and Subsidiaries
    • 10.4 Recent Developments
    • 10.5 Novo Nordisk A/S Pipeline Products
  • 11 Bayer HealthCare AG Company Profile
    • 11.1 Company Overview
    • 11.2 Business Overview
    • 11.3 Value Chain Analysis
    • 11.4 SWOT Analysis
    • 11.5 Locations and Subsidiaries
    • 11.6 Financial Deals Landscape
    • 11.7 Recent Developments
    • 11.8 Bayer HealthCare AG Pipeline Products
  • 12 Regulation System
    • 12.1 Medical Equipment Approval Process
    • 12.2 Post Market Surveillance (PMS)
  • 13 Pricing and Reimbursement
    • 13.1 Pricing and Reimbursement Policies
  • 14 Distribution Structure
  • 15 Appendix
    • 15.1 Global Markets Direct Research Methodology
    • 15.2 Coverage
    • 15.3 Secondary Research
    • 15.4 Primary Research
    • 15.5 Models
    • 15.6 Forecasts
    • 15.7 Expert Panels
    • 15.8 Currency Conversion
    • 15.9 Contact Us
    • 15.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Number of Doctors by Specialty in France, 2003-2007
    • Table 2: Number of Hospital Wards by Specialty in France, 2003-2007
    • Table 3: Diabetes Care Devices, France, Overall Revenues ($ mn), 2000-2012
    • Table 4: Diabetes Care Devices, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 5: Diabetes Care Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 6: Diabetes Care Devices, France, Overall Revenues ($ mn), 2000-2012
    • Table 7: Diabetes Care Devices, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 8: Diabetes Care Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 9: Diabetes Care Devices, France, Overall Volume (Units), 2000-2012
    • Table 10: Diabetes Care Devices, France, Overall Volume (Units), Historic, 2000-2007
    • Table 11: Diabetes Care Devices, France, Overall Volume (Units), Forecast, 2007-2012
    • Table 12: Diabetes Care Devices, France, Overall Company Share by Revenue ($ mn), 2006-2007
    • Table 13: Glucose Monitoring, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 14: Glucose Monitoring, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 15: Glucose Monitoring, France, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 16: Glucose Monitoring, France, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 17: Blood Glucose Test Strips, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 18: Blood Glucose Test Strips, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 19: Blood Glucose Meters, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 20: Blood Glucose Meters, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 21: Glucose Monitoring, France, Overall Volume (Units), Historic, 2000-2007
    • Table 22: Glucose Monitoring, France, Overall Volume (Units), Forecast, 2007-2012
    • Table 23: Blood Glucose Test Strips, France, Overall Volume (Units), Historic, 2000-2007
    • Table 24: Blood Glucose Test Strips, France, Overall Volume (Units), Forecast, 2007-2012
    • Table 25: Blood Glucose Meters, France, Overall Volume (Units), Historic, 2000-2007
    • Table 26: Blood Glucose Meters, France, Overall Volume (Units), Forecast, 2007-2012
    • Table 27: Blood Glucose Meters, France, Average Price ($), Historic, 2000-2007
    • Table 28: Blood Glucose Meters, France, Average Price ($), Forecast, 2007-2012
    • Table 29: Blood Glucose Test Strips, France, Average Price ($), Historic, 2000-2007
    • Table 30: Blood Glucose Test Strips, France, Average Price ($), Forecast, 2007-2012
    • Table 31: Glucose Monitoring, France, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 32: Glucose Monitoring, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 33: Insulin Delivery, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 34: Insulin Delivery, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 35: Insulin Delivery, France, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 36: Insulin Delivery, France, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 37: Insulin Pens, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 38: Insulin Pens, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 39: Insulin Pumps, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 40: Insulin Pumps, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 41: Insulin Syringes, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 42: Insulin Syringes, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 43: Insulin Jet Injectors, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 44: Insulin Jet Injectors, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 45: Insulin Delivery, France, Overall Volume (Units), Historic, 2000-2007
    • Table 46: Insulin Delivery, France, Overall Volume (Units), Forecast, 2007-2012
    • Table 47: Insulin Syringes, France, Overall Volume (Units), Historic, 2000-2007
    • Table 48: Insulin Syringes, France, Overall Volume (Units), Forecast, 2007-2012
    • Table 49: Insulin Pens, France, Overall Volume (Units), Historic, 2000-2007
    • Table 50: Insulin Pens, France, Overall Volume (Units), Forecast, 2007-2012
    • Table 51: Insulin Pumps, France, Overall Volume (Units), Historic, 2000-2007
    • Table 52: Insulin Pumps, France, Overall Volume (Units), Forecast, 2007-2012
    • Table 53: Insulin Jet Injectors, France, Overall Volume (Units), Historic, 2000-2007
    • Table 54: Insulin Jet Injectors, France, Overall Volume (Units), Forecast, 2007-2012
    • Table 55: Insulin Jet Injectors, France, Average Price ($), Historic, 2000-2007
    • Table 56: Insulin Jet Injectors, France, Average Price ($), Forecast, 2007-2012
    • Table 57: Insulin Pens, France, Average Price ($), Historic, 2000-2007
    • Table 58: Insulin Pens, France, Average Price ($), Forecast, 2007-2012
    • Table 59: Insulin Pumps, France, Average Price ($), Historic, 2000-2007
    • Table 60: Insulin Pumps, France, Average Price ($), Forecast, 2007-2012
    • Table 61: Insulin Syringes, France, Average Price ($), Historic, 2000-2007
    • Table 62: Insulin Syringes, France, Average Price ($), Forecast, 2007-2012
    • Table 63: Insulin Delivery, France, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 64: Insulin Delivery, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 65: F. Hoffmann-La Roche Ltd., SWOT Analysis, 2006
    • Table 66: F. Hoffmann-La Roche Ltd., Financial Statements, CHF Million, 2002-2006
    • Table 67: F. Hoffmann-La Roche Ltd., Financial Ratios, CHF Million, 2002-2006
    • Table 68: F. Hoffmann-La Roche Ltd., Other Locations
    • Table 69: F. Hoffmann-La Roche Ltd., Other Locations(Contd)
    • Table 70: F. Hoffmann-La Roche Ltd., Subsidiaries
    • Table 71: LifeScan, Inc., Other Locations
    • Table 72: Abbott Laboratories, SWOT Analysis, 2006
    • Table 73: Abbott Laboratories, Financial Statements, USD Thousand, 2002-2006
    • Table 74: Abbott Laboratories, Financial Ratios, USD Thousand, 2002-2006
    • Table 75: Abbott Laboratories, Other Locations
    • Table 76: Abbott Laboratories, Subsidiaries
    • Table 77: Novo Nordisk A/S, Other Locations
    • Table 78: Novo Nordisk A/S, Subsidiaries
    • Table 79: Bayer HealthCare AG, SWOT Analysis
    • Table 80: Bayer HealthCare AG, Other Locations
    • Table 81: Currency Conversion from USD to Local Currency at 2007 Constant Rate
    • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in France, 2000 - 2006
    • Figure 2: Diabetes Care Devices, France, Overall Revenues ($ mn), 2000-2012
    • Figure 3: Diabetes Care Devices, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 4: Diabetes Care Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 5: Diabetes Care Devices, France, Overall Revenues ($ mn), 2000-2012
    • Figure 6: Diabetes Care Devices, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 7: Diabetes Care Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 8: Diabetes Care Devices, France, Overall Volume (Units), 2000-2012
    • Figure 9: Diabetes Care Devices, France, Overall Volume (Units), Historic, 2000-2007
    • Figure 10: Diabetes Care Devices, France, Overall Volume (Units), Forecast, 2007-2012
    • Figure 11: Diabetes Care Devices, France, Overall Company Share (%), 2007
    • Figure 12: Glucose Monitoring, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 13: Glucose Monitoring, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 14: Glucose Monitoring, France, Revenue by Segment ($ mn), Historic, 2000-2007
    • Figure 15: Glucose Monitoring, France, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Figure 16: Blood Glucose Test Strips, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 17: Blood Glucose Test Strips, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 18: Blood Glucose Meters, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 19: Blood Glucose Meters, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 20: Glucose Monitoring, France, Overall Volume (Units), Historic, 2000-2007
    • Figure 21: Glucose Monitoring, France, Overall Volume (Units), Forecast, 2007-2012
    • Figure 22: Blood Glucose Test Strips, France, Overall Volume (Units), Historic, 2000-2007
    • Figure 23: Blood Glucose Test Strips, France, Overall Volume (Units), Forecast, 2007-2012
    • Figure 24: Blood Glucose Meters, France, Overall Volume (Units), Historic, 2000-2007
    • Figure 25: Blood Glucose Meters, France, Overall Volume (Units), Forecast, 2007-2012
    • Figure 26: Blood Glucose Meters, France, Average Price ($), Historic, 2000-2007
    • Figure 27: Blood Glucose Meters, France, Average Price ($), Forecast, 2007-2012
    • Figure 28: Blood Glucose Test Strips, France, Average Price ($), Historic, 2000-2007
    • Figure 29: Blood Glucose Test Strips, France, Average Price ($), Forecast, 2007-2012
    • Figure 30: Glucose Monitoring, France, Distribution Share (%), 2007
    • Figure 31: Glucose Monitoring, France, Company Share (%), 2007
    • Figure 32: Insulin Delivery, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 33: Insulin Delivery, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 34: Insulin Delivery, France, Revenue by Segment ($ mn), Historic, 2000-2007
    • Figure 35: Insulin Delivery, France, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Figure 36: Insulin Pens, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 37: Insulin Pens, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 38: Insulin Pumps, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 39: Insulin Pumps, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 40: Insulin Syringes, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 41: Insulin Syringes, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 42: Insulin Jet Injectors, France, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 43: Insulin Jet Injectors, France, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 44: Insulin Syringes, France, Overall Volume (Units), Historic, 2000-2007
    • Figure 45: Insulin Syringes, France, Overall Volume (Units), Forecast, 2007-2012
    • Figure 46: Insulin Pens, France, Overall Volume (Units), Historic, 2000-2007
    • Figure 47: Insulin Pens, France, Overall Volume (Units), Forecast, 2007-2012
    • Figure 48: Insulin Pumps, France, Overall Volume (Units), Historic, 2000-2007
    • Figure 49: Insulin Pumps, France, Overall Volume (Units), Forecast, 2007-2012
    • Figure 50: Insulin Jet Injectors, France, Overall Volume (Units), Historic, 2000-2007
    • Figure 51: Insulin Jet Injectors, France, Overall Volume (Units), Forecast, 2007-2012
    • Figure 52: Insulin Jet Injectors, France, Average Price ($), Historic, 2000-2007
    • Figure 53: Insulin Jet Injectors, France, Average Price ($), Forecast, 2007-2012
    • Figure 54: Insulin Pens, France, Average Price ($), Historic, 2000-2007
    • Figure 55: Insulin Pens, France, Average Price ($), Forecast, 2007-2012
    • Figure 56: Insulin Pumps, France, Average Price ($), Historic, 2000-2007
    • Figure 57: Insulin Pumps, France, Average Price ($), Forecast, 2007-2012
    • Figure 58: Insulin Syringes, France, Average Price ($), Historic, 2000-2007
    • Figure 59: Insulin Syringes, France, Average Price ($), Forecast, 2007-2012
    • Figure 60: Insulin Delivery, France, Distribution Share (%), 2007
    • Figure 61: Insulin Delivery, France, Company Share (%), 2007
    • Figure 62: F. Hoffmann-La Roche Ltd., Value Chain Analysis
    • Figure 63: Abbott Laboratories, Value Chain Analysis
    • Figure 64: Bayer HealthCare AG, Value Chain Analysis
    • Figure 65: Flowchart for Classification of Non-invasive Devices in France, 2007
    • Figure 66: Flowchart for Classification of Invasive Devices in France, 2007
    • Figure 67: Flowchart for Classification of Invasive Devices in France, 2007
    • Figure 68: Flowchart for Classification of Invasive Devices in France, 2007
    • Figure 69: Flowchart for Classification of Invasive Devices in France, 2007
    • Figure 70: Flowchart for Classification of Active Devices in France, 2007
    • Figure 71: Flowchart for Classification of Active Devices in France, 2007
    • Figure 72: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in France, 2007
    • Figure 73: Conformity Assessment of Class-I Medical Devices in France, 2007
    • Figure 74: Conformity Assessment of Class-IIa Medical Devices in France, 2007
    • Figure 75: Conformity Assessment of Class-IIb Medical Devices in France, 2007
    • Figure 76: Conformity Assessment of Class-III Medical Devices in France, 2007
    • Figure 77: Medical Equipment Distribution Structure in France, 2007
    • Figure 78: Global Markets Direct Methodology